2 research outputs found
Continuous-time quantum walks for MAX-CUT are hot
By exploiting the link between time-independent Hamiltonians and
thermalisation, heuristic predictions on the performance of continuous-time
quantum walks for MAX-CUT are made. The resulting predictions depend on the
number of triangles in the underlying MAX-CUT graph. We extend these results to
the time-dependent setting with multi-stage quantum walks and Floquet systems.
The approach followed here provides a novel way of understanding the role of
unitary dynamics in tackling combinatorial optimisation problems with
continuous-time quantum algorithms.Comment: 25 pages, 29 figure
Cell-autonomous requirement for ACE2 across organs in lethal mouse SARS-CoV-2 infection.
Angiotensin-converting enzyme 2 (ACE2) is the cell-surface receptor for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). While its central role in Coronavirus Disease 2019 (COVID-19) pathogenesis is indisputable, there remains significant debate regarding the role of this transmembrane carboxypeptidase in the disease course. These include the role of soluble versus membrane-bound ACE2, as well as ACE2-independent mechanisms that may contribute to viral spread. Testing these roles requires in vivo models. Here, we report humanized ACE2-floxed mice in which hACE2 is expressed from the mouse Ace2 locus in a manner that confers lethal disease and permits cell-specific, Cre-mediated loss of function, and LSL-hACE2 mice in which hACE2 is expressed from the Rosa26 locus enabling cell-specific, Cre-mediated gain of function. Following exposure to SARS-CoV-2, hACE2-floxed mice experienced lethal cachexia, pulmonary infiltrates, intravascular thrombosis and hypoxemia-hallmarks of severe COVID-19. Cre-mediated loss and gain of hACE2 demonstrate that neuronal infection confers lethal cachexia, hypoxemia, and respiratory failure in the absence of lung epithelial infection. In this series of genetic experiments, we demonstrate that ACE2 is absolutely and cell-autonomously required for SARS-CoV-2 infection in the olfactory epithelium, brain, and lung across diverse cell types. Therapies inhibiting or blocking ACE2 at these different sites are likely to be an effective strategy towards preventing severe COVID-19